Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2016 Oct 7;15(12):2863–2874. doi: 10.1158/1535-7163.MCT-16-0515

Figure 5. Effect of treatment with fisetin, cabazitaxel and their combination on metastasis and angiogenesis in a subcutaneous PC3M-luc-6 xenograft model.

Figure 5

Representative blots showing the effect of fisetin and cabazitaxel treatment on metastasis. A. Anti-MMP-2. B. Anti-MMP-9. Angiogenesis, C. Anti-CD31 activity and D. Anti-UPA. Data are shown as representative of three independent experiments. GAPDH served as a loading control. Bands were measured using densitometry and values first normalized to respective GAPDH bands and then reported below each gel as relative to control.